claimgotdeniedAnalyze

Hemgenix (etranacogene dezaparvovec) prior authorization denied appeal

Gene therapy for hemophilia B

To appeal a denied prior authorization for Hemgenix (etranacogene dezaparvovec), file a written appeal within 180 days. The appeal must cite the insurer's clinical policy, include a letter of medical necessity from the prescriber, and document each criterion the policy requires. The most common winning evidence is documented prior therapy history and a specialist letter.

Typical PA criteria

  • Hemophilia B with FIX activity ≤2%
  • Currently on FIX prophylaxis or history of severe bleeding
  • AAV5 neutralizing antibody testing
  • Hematologist at hemophilia treatment center
  • LFT monitoring plan

Why your PA was denied

  • AAV5 NAb testing not on file
  • FIX activity documentation missing
  • Non-HTC prescriber
  • Site-of-care not approved for gene therapy administration

Evidence that overturns the denial

  • ✓FIX activity level
  • ✓AAV5 NAb negative result
  • ✓Bleed history and current prophylaxis regimen
  • ✓Hemophilia treatment center letter
  • ✓Site-of-care attestation

One-time gene therapy priced at ~$3.5M list; site-of-care and outcomes-based contracts drive most PA logic. Nearly all approvals require single-case agreement.

Draft a Hemgenix (etranacogene dezaparvovec) appeal letter

Free analysis identifies the cited policy and missing evidence. Then a finished letter that maps your chart to the criteria.

Draft my appeal letter

FAQ

Why was my Hemgenix (etranacogene dezaparvovec) prior authorization denied?+

The most common reasons are: AAV5 NAb testing not on file; FIX activity documentation missing; Non-HTC prescriber. Your denial letter names the specific criteria you did not meet.

How do I appeal a Hemgenix (etranacogene dezaparvovec) denial?+

File a written appeal within 180 days that cites the insurer's clinical policy, includes a letter of medical necessity from the prescriber, and documents the criteria the insurer requires.

What evidence overturns a Hemgenix (etranacogene dezaparvovec) denial?+

FIX activity level; AAV5 NAb negative result; Bleed history and current prophylaxis regimen.

What if the plan excludes Hemgenix (etranacogene dezaparvovec) entirely?+

Plan exclusions are different from medical-necessity denials. Check the Summary Plan Description. If the drug is fully excluded, an appeal will not overturn it; you may need a formulary exception or manufacturer assistance program.

Other drugs

Keep reading

Not legal or medical advice. This page is a self-help resource. You make your own decisions. Strip personal identifiers (name, date of birth, address, member ID) from any document before uploading or sharing. The information here summarizes commonly-published payer policies and federal rules; confirm against your specific plan document and the current denial letter before acting.